Son güncelleme :
19/11/2024
Antifungal   Amphotericin B cholesteryl sulfate complex  
Enjeksiyon
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar pdf
   Kimyasal yapı   

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amphotec Amerika Birleşik Devletleri, Avusturya, Büyük Britanya, Polonya, Slovenya, Türkiye, Yunanistan
Kaynaklar   Enjeksiyon    Kaynaklar : Amphotericin B cholesteryl sulfate complex  
tip yayın
921 Dergi Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1407 Dergi Xu QA, Trissel LA, Gilbert DL.
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Hosp Pharm 1998 ; 33: 1203-1207.
1982 Dergi Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262 Dergi Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3578 Laboratuar Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644 Laboratuar Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010

  Mentions Légales